ArticleBMC bioinformatics2019
GCAC: galaxy workflow system for predictive model building for virtual screening.
Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Graph-Based Feature Selection Approach for Molecular Activity Prediction.Journal of chemical information and modeling · 2022Article
- Artificial intelligence to deep learning: machine intelligence approach for drug discovery.Molecular diversity · 2021Review
- Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.Drug discovery today · 2020Review
- Influence of feature rankers in the construction of molecular activity prediction models.Journal of computer-aided molecular design · 2020Article
- Big Data and Artificial Intelligence Modeling for Drug Discovery.Annual review of pharmacology and toxicology · 2020Review
- APBioNet's annual International Conference on Bioinformatics (InCoB) returns to India in 2018.BMC genomics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraditional drug discovery approaches are time-consuming, tedious and expensive. Identifying a potential drug-like molecule using high throughput screening (HTS) with high confidence is always a challenging task in drug discovery and cheminformatics. A small percentage of molecules that pass the clinical trial phases receives FDA approval. This whole process takes 10-12 years and millions of dollar of investment. The inconsistency in HTS is also a challenge for reproducible results. Reproducible research in computational research is highly desirable as a measure to evaluate scientific claims and published findings. This paper describes the development and availability of a knowledge based predictive model building system using the R Statistical Computing Environment and its ensured reproducibility using Galaxy workflow system.
resultsWe describe a web-enabled data mining analysis pipeline which employs reproducible research approaches to confront the issue of availability of tools in high throughput virtual screening. The pipeline, named as "Galaxy for Compound Activity Classification (GCAC)" includes descriptor calculation, feature selection, model building, and screening to extract potent candidates, by leveraging the combined capabilities of R statistical packages and literate programming tools contained within a workflow system environment with automated configuration.
conclusionGCAC can serve as a standard for screening drug candidates using predictive model building under galaxy environment, allowing for easy installation and reproducibility. A demo site of the tool is available at http://ccbb.jnu.ac.in/gcac.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.